Synairgen Future Growth

Synairgen is forecast to grow earnings at 40.6% per annum. EPS is expected to grow by 40.6% per annum.

40.6%

Earnings growth rate

40.6%

EPS growth rate

No updates

Earnings and Revenue Growth Forecasts

DB:OMY - Analysts future estimates and past financials data (GBP Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2023	N/A	-10	-4	-4	N/A
3/31/2023	N/A	-14	-9	-9	N/A
12/31/2022	N/A	-18	-14	-14	N/A
9/30/2022	N/A	-23	-21	-21	N/A
6/30/2022	N/A	-28	-28	-28	N/A
3/31/2022	N/A	-38	-35	-35	N/A
12/31/2021	N/A	-49	-41	-41	N/A
9/30/2021	N/A	-46	-44	-44	N/A
6/30/2021	N/A	-43	-48	-48	N/A
3/31/2021	N/A	-28	-36	-36	N/A
12/31/2020	N/A	-14	-24	-24	N/A
9/30/2020	N/A	-10	-15	-15	N/A
6/30/2020	N/A	-6	-6	-6	N/A
3/31/2020	N/A	-5	-4	-4	N/A
12/31/2019	N/A	-4	-3	-3	N/A
9/30/2019	0	-4	-4	-4	N/A
6/30/2019	0	-4	-4	-4	N/A
3/31/2019	0	-3	-4	-4	N/A
12/31/2018	0	-3	-4	-4	N/A
9/30/2018	3	-1	-1	-1	N/A
6/30/2018	5	2	2	2	N/A
3/31/2018	5	2	2	2	N/A
12/31/2017	5	2	2	2	N/A
9/30/2017	3	0	-1	-1	N/A
6/30/2017	0	-3	-3	-3	N/A
3/31/2017	0	-3	N/A	-3	N/A
12/31/2016	N/A	-3	N/A	-3	N/A
9/30/2016	N/A	-3	N/A	-3	N/A
6/30/2016	N/A	-3	N/A	-2	N/A
3/31/2016	0	-2	N/A	-2	N/A
12/31/2015	0	-2	N/A	-2	N/A
9/30/2015	0	-2	N/A	-2	N/A
6/30/2015	0	-2	N/A	-2	N/A
3/31/2015	2	0	N/A	0	N/A
12/31/2014	4	1	N/A	2	N/A
9/30/2014	4	1	N/A	2	N/A
6/30/2014	4	1	N/A	3	N/A
3/31/2014	2	-1	N/A	0	N/A
12/31/2013	N/A	-2	N/A	-2	N/A
9/30/2013	N/A	-2	N/A	-2	N/A

Earnings vs Savings Rate: OMY is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: OMY is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: OMY is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: Insufficient data to determine if OMY's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if OMY's revenue is forecast to grow faster than 20% per year.

Future ROE: OMY is forecast to be unprofitable in 3 years.